In March 2026 the International Volleyball Federation (FIVB) has reported an anti-doping rule violation against the Iranian Athlete after his A and B samples tested positive for the prohibited substances boldenone and metandienone. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the FIVB Disciplinary Panel.
The athlete stated that he had used two medications that could have caused the positive test result without intention to enhance his performanc. He had received a dexamethasone injection for his cold and sore throat and he took a Methan 10 pill recommended by a trainer at his fitness centre.
The Panel finds that the Athlete failed to explain how the substance entered his system and could not establish that the violation wasn’t intentional without additional supporting evidence. The Panel notice that when the Athlete had been more educated by his national federation about doping he should have researched his medication and products before using.
Without grounds for a reduced sanction the FIVB Disciplinary Panel decides on 5 September 2016 to impose a 4 year period of ineligibility on the Athlete, starting on 24 March 2016.
